Antipsychotic medication

Latuda (lurasidone) is an antipsychotic medication. It works by changing the effects of chemicals in the brain. Latuda is used to treat schizophrenia in adults. It is also used to treat depression associated with bipolar. Latuda is not for use in psychotic conditions related to dementia. This drug may cause heart failure, sudden death, or pneumonia in older adults with dementia-related conditions. You should not use Latuda if you are allergic to lurasidone. Latuda was formulated in October 28, 2010. It is supplied as a tablet for oral administrations.

The recommended starting dose is 40 mg once daily and the maximum recommended dose is 80 mg/day.

Latuda should be taken with food. Dose adjustments are recommended for the following: patients with moderate and severe renal impairment, patients with moderate and severe hepatic impairment, patients taking concomitant (existing or occurring with something else concurrently) potential inhibitors and patients taking concomitant potential inducers. Mechanism of action, atypical antipsychotic; precise mechanism is unknown; efficacy suggested involve medication of central dopamine type 2 and serotonin type 2 Any of these signs of an allergic reaction to Latuda require emergency medical help: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Get quality help now

Prof. Finch

Verified writer

Proficient in: Bipolar Disorder

4.7 (346)

“ This writer never make an mistake for me always deliver long before due date. Am telling you man this writer is absolutely the best. ”

+84 relevant experts are online

Hire writer

Serious side effects such as: dizziness, fainting, fast or pounding heartbeats; agitation, hostility, confusion, thought about hurting yourself or seizure’s should stop taking Latuda and call your doctor.

A total of 831 drugs are known to interact with Latuda (lurasidone). 70 major drug interactions, 759 moderate drug interactions and 2 minor drug interactions. The disadvantages of taking Latuda are that there is increased mortality in elderly patients with Dementia-Related Psychosis.